Enhanced invasiveness of tumour cells after host exposure to heavy metals

European Journal of Cancer Part A

Volumn 32, Issue 13, 1996, Pages 2342-2347

  Haga, A ^a   Nagase, H ^a   Kito, H ^a   Sato, T ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Heavy metals; Invasiveness; Tumour cells

Indexed keywords

CADMIUM; CISPLATIN; HEAVY METAL; METALLOTHIONEIN; ZINC;

ARTICLE; CANCER CELL; CANCER INVASION; ENDOTHELIUM CELL; FIBROBLAST; FIBROSARCOMA; HUMAN; HUMAN CELL; MELANOMA; METASTASIS; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

ANIMALS; CADMIUM; CISPLATIN; FIBROSARCOMA; HUMANS; METALLOTHIONEIN; METALS, HEAVY; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; TUMOR CELLS, CULTURED; ZINC;

EID: 0030478908     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00349-8     Document Type: Article

References (38)

1. 1. Fidler IJ. Critical factors in the biology of human cancer metastastis: Twenty-eighth G.H.A. Clowes Memorial Award lecture. Cancer Res 1990, 50, 6130-6138.
2. 2. Liotta LA, Kohn E. Cancer invasion and metastases. JAMA 1990, 263, 1123-1126.
3. 3. Liotta LA, Mandler R, Murano G, et al. Tumor cell autocrine motility factor. Proc Natl Acad Sci USA 1986, 83, 3302-3306.
4. 4. Terranova VP, Liotta LA, Russo RG, Martin GR. Role of laminin in attachment and metastasis of murine tumor cells. Cancer Res 1982, 42, 2265-2269.
5. 5. Stetler-Stevenson WG. Type IV collagenases in tumor invasion and metastasis. Cancer Metast Rev 1990, 9, 289-303.
6. 6. Nakajima M, Chop AM. Tumor invasion and extracellular matrix degradative enzymes: regulation of activity by organ factors. Cancer Biol 1991, 2, 115-127.
7. 7. Wright EB, Dormandy TL. Liver zinc in carcinoma. Nature 1972, 237, 166.
8. 8. Griffith K, Wright EB, Dormandy TL. Tissue zinc in malignant disease. Nature 1973, 241, 60.
9. 9. Takeda A, Sato T, Tamano H, Okada S. Elevation of hepatic levels of metallothionein and zinc in mice bearing experimental tumors. Biochem Biophys Res Commun 1992, 189, 645-649.
10. 10. Shirai T, Iwasaki S, Masui T, Mori T, Kato T, Ito N. Enhancing effect of cadmium on rat ventral prostate carcinogenesis induced by 3,2'-dimethyl-4-aminobiphenyl. Jpn J Cancer Res 1993, 84, 1023-1030.
11. 11. Satoh M, Kloth DM, Kadhim SA, et al. Modulation of both cisplatin nephrotoxicity and drug resistance in murine bladder tumor by controlling metallothionein synthesis. Cancer Res 1993, 53, 1829-1832.
12. 12. Waalkes MP, Goering PL. Metallothionein and other cadmium-binding proteins: recent developments. Chem Res Toxicol 1990, 3, 281-288.
13. 13. Tsuruo T. Mechanism of multidrug resistance and implications for therapy. Jpn J Cancer Res 1988, 79, 285-296.
14. 14. Rasheed S, Nelson-Rees WA, Toth EM, Amstein P, Gardner MB. Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer 1974, 33, 1027-1033.
15. 15. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965, 37, 614-636.
16. 16. Hagiwara H, Shimonaka M, Morisaki M, Ikekawa N, Inada Y. Sitosterol-stimulative production of plasminogen activator in cultured endothelial cells from bovine carotid artery. Thromb Res 1984, 33, 363-370.
17. 17. Hart IR. The selection and characterization of an invasive variant of the B16 melanoma. Am J Pathol 1979, 97, 587-600.
18. 18. Akedo H, Shinkai K, Mukai M, Mori Y, Tateishi R, Tanaka K. Interaction of rat ascites hepatoma cells with cultured mesothelial cell layers: a model for tumor invasion. Cancer Res 1986, 46, 2416-2422.
19. 19. Mantovani A, Bussolino F, Dejana E. Cytokine regulation of endothelial cell function. FASEB J 1992, 6, 2591-2599.
20. 20. Onosaka S, Tanaka K, Doi M, Okahara K. A simplified procedure for determination of metallothionein in animal tissues. Eisei Kagaku 1978, 24, 128-131.
21. 21. Easty GC, Easty DM. An organ culture system for the examination of tumor invasion. Nature 1963, 199, 1104-1105.
22. 22. Nicolson GL, Dulski K, Basson C, Welch DR. Preferential organ attachment and invasion in vitro by B16 melanoma cells selected for differing metastatic colonization and invasive properties. Invas Metast 1985, 5, 144-158.
23. 23. Tsunoo H, Kino K, Nakajima H, Hata A, Huang I-Y, Yoshida A. Mouse liver metallothionein. J Biol Chem 1978, 253, 4172-4174.
24. 24. Kato Y, Nakayama Y, Umeda M, Miyazaki K. Induction of 103 kDa gelatinase/type IV collagenase by acidic culture conditions in mouse melanoma cell lines. J Biol Chem 1992, 267, 11424-11430.
25. 25. Morodomi T, Ogata Y, Sasaguri Y, Morimatsu M, Nagase H. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic and HT1080 fibrosarcoma cells. Biochem J Leukemia, 603-611.
26. 26. Okada Y, Gonoji Y, Maka K, et al. Matrix metalloproteinase 9 (92-kDa gelatinase/Type IV collagenase) from HT 1080 human fibrosarcoma cells. J Biol Chem 1992, 267, 21712-21719.
27. 27. Nagase H, Haga A, Kito H, Sasaki K, Sato T. Enhancing effect of metallothionein on tumor cells invasion in vitro. Cancer Res Ther Control 1995, 4, 301-307.
28. 28. Sato H, Takino T, Okada Y, et al. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 1994, 370, 61-65.
29. 29. Poulsom R, Pignatelli M, Sterler-Stevenson WG, et al. Stromal expression of 72 kDa type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol 1992, 141, 389-396.
30. 30. Soini Y, Paakko P, Autio-Harmainen H. Genes of laminin B1 chain, α 1 (IV) chain of type IV collagen, and 72-kDa type IV collagenase are mainly expressed by the stromal cells of lung carcinomas. Am J Pathol 1993, 142, 1622-1630.
31. 31. Okada Y, Morodomi T, Enghild JJ, et al. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur J Biochem 1990, 194, 721-730.
32. 32. Overall CM, Sodek J. Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. J Biol Chem 1990, 265, 21141-21151.
33. 33. Docherty AJP, O'Connel J, Crabbe T, Angal S, Murphy G. The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases. Trends Biotechnol 1992, 10, 200-207.
34. 34. Haga A, Nagase H, Kito H, Sato T. Effect of metallothioneins on transformation of gelatinase A from human fibroblast WI-38 cells. Cancer Lett 1996, 105, 175-180.
35. 35. Failla ML, Cousins RJ. Zinc uptake by isolated rat liver parenchymal cells. Biochim Biophys Acta 1978, 538, 435-444.
36. 36. Karin M, Andersen RD, Slater E, Smith K, Herschman HR. Metallothionein mRNA induction in Hela cells in response to zinc or dexamethasone is a primary induction response. Nature 1980, 286, 295-297.
37. 37. Onosaka S, Cherian MG. The induced synthesis of metallothionein in various tissues of rat in response to metals. I. Effect of repeated injection of cadmium salts. Toxicology 1981, 22, 91-101.
38. 38. Satoh M, Kloth DM, Kadhim SA, et al. Modulation of both cisplatin nephrotoxicity and drug resistance in murine bladder tumor by controlling metallothionein synthesis. Cancer Res 1993, 53, 1829-1832.